MLAB
NASDAQ
US
Mesa Laboratories, Inc. - Common Stock
$91.08
▲ +$2.62
(+2.96%)
Vol 91K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$433.5M
ROE
-0.9%
Margin
-0.6%
D/E
97.97
Beta
0.88
Div Yield
0.82%
52W
$55–$155
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
3
Buy
3
Hold
0
Sell
0
Strong Sell
66.7%
Buy Rating
Price Chart
Similar Stocks
AZTA
Azenta Inc
$1.5B
BLFS
BioLife Solutions Inc
$1.2B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
CYRX
Cryoport Inc
P/E 7.1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
LAB
Standard BioTools Inc
$492.2M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.28 | $0.65 | +$0.37 |
| Sep 2025 | $0.16 | $0.45 | +$0.29 |
| Jun 2025 | $0.45 | $0.85 | +$0.40 |
| Mar 2025 | $1.11 | $-1.31 | $-2.42 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -0.4% | -1.3% | -0.4% | -0.4% | -0.9% | -0.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 8.0% | -0.8% | -0.3% | -0.3% | -0.6% | -0.6% |
| Gross Margin | 62.0% | 62.6% | 62.1% | 62.1% | 62.1% | 62.1% |
| D/E Ratio | 105.04 | 111.34 | 105.04 | 105.04 | 97.97 | 97.97 |
| Current Ratio | 0.66 | 0.63 | 0.66 | 0.66 | 2.02 | 2.02 |
Key Ratios
ROA (TTM)
-0.4%
P/S (TTM)
1.77
P/B
4.0
EPS (TTM)
$-0.31
CF/Share
$6.17
Rev Growth 3Y
+9.4%
52W High
$155.12
52W Low
$55.45
$55.45
52-Week Range
$155.12
How does MLAB compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
MLAB valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
1.8
▼
54%
below
peers
(3.8)
vs Peers
vs Industry
Undervalued
P/B ratio
4.0
▲
8%
above
peers
(3.7)
vs Peers
vs Industry
Fair value
Div yield
0.8%
▲
70%
above
peers
(0.5%)
vs Peers
vs Industry
Low yield
MLAB profitability vs Life Sciences Tools & Services peers
ROE
-0.9%
▲
71%
above
peers
(-3.3%)
vs Peers
vs Industry
Below avg
Net margin
-0.6%
▲
93%
above
peers
(-9.4%)
vs Peers
vs Industry
Below avg
Gross margin
62.2%
▲
29%
above
peers
(48.0%)
vs Peers
vs Industry
Top tier
ROA
-0.4%
▲
86%
above
peers
(-2.6%)
vs Peers
vs Industry
Below avg
MLAB financial health vs Life Sciences Tools & Services peers
D/E ratio
98.0
▲
168%
above
peers
(36.5)
vs Peers
vs Industry
High debt
Current ratio
2.0
▼
40%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
38%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
MLAB fundamentals radar
MLAB
Peer median
Industry
MLAB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MLAB vs peers: key metrics
Latest News
No related news yet